Approvals/TGA/CSL New Zealand Hizentra NZ Human Normal Immunoglobulin (20%) solution for subcutaneous injection

Approved

STANDARD

CSL New Zealand Hizentra NZ Human Normal Immunoglobulin (20%) solution for subcutaneous injection

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d89f38723eec644d
Product Name: CSL New Zealand Hizentra NZ Human Normal Immunoglobulin (20%) solution for subcutaneous injection
Artg Id: 416100
Artg Name: CSL New Zealand Hizentra NZ Human Normal Immunoglobulin (20%) solution for subcutaneous injection
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2023-08-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

d89f38723eec644d

Type

Standard